68results about How to "Absence" patented technology

Expandable stents are disclosed. The stents have a plurality of rings or modules interconnected in series, with selectable links between the rings to provide for articulation. The preferred stent includes a plurality of modules, each of the modules being radially interconnected to form a ring configured to be expandably interconnected and being interconnected to each other in series by respective interconnection bridges. Each ring including a continuous strand of a material, the continuous strand of material being interconnected end to end so as to generally encompass a radial space within the ring. The strand of material being configured to include a repeating series of interconnected repeating W-shaped strand configurations having a repeating dip, rise, dip, rise, loop, dip, rise, dip, rise, loop patterned configuration. Preferably, the continuous strand of a material has an outer surface including cavities being at least partially filled with compositions containing medicinal agents selected to provide medically desirable effects upon positioning within a patient. Preferably, the continuous strand of a material has a series of narrowings that facilitate the bending of the strand. Alternate rings have at least one and preferably a number of expansion cells. The expansion cells preferably have at least one accordion structure on each side of the cell, which allows for significant expansion. The material of the respective stents being deformable such that each ring can be deformed from a first configuration wherein each ring has a first circumference and, in certain embodiments, each expansion cell has a first radial length, to a second configuration wherein each ring has a second circumference greater than the first circumference. Methods of producing the devices are also disclosed, including various etching methods.

We describe the use of a flow directing apparatus for incorporation into a patient mask or adjacent to it and for use with a source of pressurized breathable gas such as electronically or electronically controlled fan blower or positive displacement ventilator to provide nasal or oro-nasally administered continuous positive airway pressure or bi level therapies. Such therapies are commonly used to treat sleep disordered breathing including sleep apnea and other syndromes, as well as ventilatory insufficiency. The valve apparatus includes means to direct expired air to atmosphere and inspired air from a pressure source to a user's airway. In this way advantage is provided compared to alternative means as described in the prior art which vent a user's expired gas to atmosphere through a fixed open vent.

The invention concerns compositions and methods for assay or detection of apolipoprotein-B48 in samples. In particular, it concerns a method for differential measurement of apolipoprotein-B48 (“Apo-B48”) and apolipoprotein-B100 (“Apo-B100”) in biological samples. The invention also concerns synthetic products of Apo-B100, the corresponding antibodies, kits containing same, and their uses for detecting, differentially quantifying and/or recording an amount of Apo-B48 and/or Apo-B100 in a sample, or for quantifying and/or recording atherogenic lipoparticles in a sample. The products, materials and kits hereinabove can also be used for differentially modulating the levels of Apo-B48 and/or Apo-B100 or their activity, in vitro or in vivo, and for regulating lipid metabolism in a subject.

Apparatus and methods for performing acoustical measurements are provided having some and preferably all of the following features: (1) the system is operated under near-field conditions; (2) the piezoelement or piezoelements used in the system are (a) mechanically and electrically damped and (b) efficiently electrically coupled to the signal processing components of the system; (3) each piezoelement used in the system includes an acoustical transformer for coupling the element to a gaseous test medium; (4) speed of sound is determined from the time difference between two detections of an acoustical pulse at a receiver; (5) cross-correlation techniques are employed to detect the acoustical pulse at the receiver; (6) fast Fourier transform techniques are used to implement the cross-correlation techniques; and (7) stray path signals through the body of the acoustic sensor are removed from detected signals prior to signal analysis. Techniques are also provided for performing acoustical measurements on gases whose thermodynamic properties have not been measures and on mixtures of compressible gases. Methods and apparatus for performing feedback control of a gas of interest in a mixture of that gas and a carrier gas are provided in which the controlled variable is the flow of the carrier gas.

The present invention is directed to polyurethane-urea materials and to a process for their production. These polyurethane-ureas are preferably optically clear and comprise the reaction product of a (cyclo)aliphatic polyisocyanate or prepolymer thereof, with an isocyanate-reactive component that comprises one or more aromatic diamines which contains two primary amine groups, and one or more compounds containing two secondary amine groups which may be linked to aliphatic and/or aromatic moieties. This isocyanate-reactive component may additionally comprise one or more hydroxyl-functional compounds. The present invention offers a relatively fast “Green-Cure Time” of solid polyurethane-ureas which enables these to be demolded in a relatively short time period, followed by subsequent post-curing outside the mold.

A reflector array comprises a plurality of partial parabolic reflectors arranged in rows and columns with each reflector directing radiation to a receiver or from a transmitter located at the focus of the reflector. In a compact photovoltaic cell arrangement, each cell is shielded from direct radiation by the adjacent reflector. The reflectors can be formed as one unit with reflective material or with the reflecting surfaces coated with aluminum, silver, or other suitable reflecting material. A secondary reflector can be positioned at the focus of a reflector for directing radiation to a receiver or from a transmitter located at a more accessible location in the array.

The invention features methods, compositions, and kits for the treatment of attention deficit hyperactivity disorder and related behavioral disorders by administering an organic cation 3 (hOCT3) inhibitor.

A sensor senses a characteristic of an environment, e.g., humidity. The sensor has a substrate with strips of material that is sensitive to corrosion as a result of the characteristic. The strips are configured to respond differently to the characteristic. By means of repeatedly measuring the resistances of the strips, the environment can be monitored in terms of accumulated exposure to the characteristic. The strips are manufactured in a semiconductor technology so as to generate accurate sensors that behave predictably.

The present invention relates to fast water-dispersible tablets containing domperidone for oral administration. The formulations comprise domperidone or pharmaceutically acceptable salts thereof, about 60-80% of a “auxiliary” granulate (w/w), and about 10-30% of microcrystalline cellulose (w/w), expressed in relation to the total weight of the tablets, a sweetener, a flavouring agent and a lubricant. The “auxiliary” granulate is obtained by wet granulation of D-mannitol and maize starch gum in a high shear granulator, it facilitates the flowability and the compressibility of the mixture and, because of its high solubility in water, contributes to the fast dispersion of the tablet. The formulations have an enhanced structural integrity, for instance having a friability lower than 1.0% and hardness values between 3 and 6 Kp, and are able to disperse in water within 3 minutes, preferably within 2 minutes and most preferably within 1 minute, to provide a dispersion that passes through a 710 μm diameter mesh size sieve and presents a pleasant taste and the absence of perceptible granules in the mouth. This invention also refers to the process for the preparation of said pharmaceutical preparations.

The present invention relates to the use of a low-caloric high-protein nutritional composition for use in the prevention or treatment of a disease or condition in a mammal, which involves muscle decline, as well as to specific low-caloric high-protein nutritional compositions for stimulating muscle protein synthesis in a mammal. In particular, the invention relates to the use of a nutritional composition comprising per 100 kcal: (i) at least about 12 g of proteinaceous matter which comprises at least about 80 weight % of whey protein, relative to the total proteinaceous matter, and which comprises at least about 11 weight % of leucine, relative to the total proteinaceous matter, of which at least about 20 weight % is in a free form, relative to the total leucine, (ii) a source of fat and a source of digestible carbohydrates, for the prevention or treatment of a disease or condition which involves muscle decline in a mammal, especially an elderly mammal, wherein the nutritional composition is administered as 1 to 2 servings daily, each serving comprising between 80 and 200 kcal.

The invention relates to the food industry, particularly to the dairy industry, and can be used for putting into use some new food technologies and producing a large number of new food products noted for improved properties. The invention is directed to raising the physiological activity of food products, particularly of fermented milk products and to improving other properties thereof. In accordance with the invention, the proposed process for producing a product (variants) comprises: (1) combining a food base or at least one of its components with at least one physiologically acceptable carrier and/or with at least one its starting component, precursor; (2) combining the food base or at least one of its components with at least one microorganism or other biological system; (3) forming at least one "carrier-biocatalyst" system; (4) participation of at least part of the microorganisms and/or other biological systems of an immobilized biocatalyst in obtaining the final product due to metabolic processes, for example, due to microbial synthesis and/or transformation of the food base (substrate); (5) providing the presence of at least one formed immobilized biocatalyst in the composition of the product. The invention discloses also products obtained in accordance with the claimed process, that are called "biocatalyzed products", as well as starters for obtaining such products.

Interconnects for connecting axially expandable segments of stents are disclosed. The interconnects include a proximal connector, a first arm, a second arm and a distal connector. The connectors secure the interconnect to the adjacent axially expandable members. The first arm and the second arm provide flexible elements of the interconnect to confer a degree of axial flexibility between the segments.

A laminated wood bat having may comprise wedges of wood adhered together in such a manner that the entire surface or sections of the surface of the bat barrel, throat, and handle have the tight grain of the normal hitting surface. Adjacent wedges of wood may be cut from the same strip of wood. The bat may be glued together with a low viscosity polyurethane adhesive.

A belt seam treatment apparatus includes a support element with a smooth surface that supports the seam region of the belt, a heat source that heats a treatment strip and the belt seam region, and a pressure applicator that forces the treatment strip against the belt seam region. The support element can be a tube over which the belt hangs and can include a vacuum belt hold system that secures the seam region against the tube during treatment. The heat source can be an infrared laser or an infrared lamp. Optics form a heat spot or a heat line on the strip and seam region, and a pressure wheel traverses the seam region after heating to compress the strip and seam and bond a thermoplastic polymer of the strip to the seam region of the belt.

The invention relates to a machine having a base (300) and at least one work station (306) that has a module (50) for electrochemically machining a workpiece (51). The module comprises: a frame (54); and an electrode arrangement, having at least one electrode (60, 160), which is mechanically connected to the frame, and a drive (56, 156) for moving this electrode, which drive is attached to the frame; a workpiece holder (310, 311) for separably attaching the workpiece; and a positioning device (312, 313) for displacing the workpiece holder and the module relative to each other.

The present invention relates to a new butter and a process for preparing same comprising: (a) grinding and mixing the starting ingredients, and (b) heat treatment at a temperature comprised between 70-150° C., wherein the starting ingredients comprise: (i) a fat selected from among cream, butter, anhydrous milk fat and mixtures thereof and (ii) at least one additive selected from the group of stabilizers, thickeners, texturing agents, emulsifiers and mixtures thereof. The invention also relates to a process for packaging the butter in a package, such as a spray type container, or a tube type container, or a dispensing package with a membrane stopper, as well as the packaged butter obtained.

A digital phase-locked loop (DPLL), a supporting digital frequency integrator, and a method are provided for deriving a digital phase error signal in a DPLL. A digital frequency integrator periodically accepts a digital tdcOUT message from a Time-to-Digital Converter (TDC) representing a measured ratio of a reference clock (Tref) period to a synthesizer clock (Tdco) period. Also accepted is a digital message selecting a first ratio (Nf). In response, a digital phase error (pherr) message is periodically supplied that is proportional to an error in phase between the reference clock and the (synthesizer clock*Nf).

A belt seam treatment apparatus includes a support element with a smooth surface that supports the seam region of the belt and a heat and pressure source that heats a treatment strip and the belt seam region and that forces the treatment strip against the belt seam region. The support element can be a tube over which the belt hangs and can include a vacuum belt hold system that secures the seam region against the tube during treatment. The heat and pressure source can be a heated pressure bar engaging the entire seam region or a heated pressure wheel traversing the seam region of the entire belt width.